The Pharmaceutical Services Negotiating Committee (PSNC) director of pharmacy funding Mike Dent told C+D that, “while there have always been...
The Department of Health and Social Care (DH) was granted powers in July 2017 to impose changes to medicine prices when it thinks “inappropriate...
The focus on the UK’s impending exit from the European Union has generated significant and widespread planning and preparation, particularly around...
The Medicines and Healthcare products Regulatory Agency (MHRA) first issued a partial suspension of the manufacturer’s licence in August 2017, after...
The court dismissed Pfizer’s attempt to prevent generic pregabalin from being used to treat certain types of pain, such as neuropathic pain,...
The latest instalment in the sector’s long-running struggles with generic pricing started in September 2017, when the Pharmaceutical Services...
Pre-tax profit for the independent H Shackleton chain in the 12 months to October 2017 fell from £496,000 to £422,000, with half the loss due to the...
Health secretary Matt Hancock announced last week that he had “asked the Department of Health and Social Care (DH) for options for stockpiling”...
A National Audit Office (NAO) report into last year’s “unexpected increase” in generics prices – published last month (June 8) – referred to...
Representatives from pharmacy, the Department of Health and Social Care (DH) and NHS England were called in front of the Public Accounts Committee –...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter